Morgan Stanley Call 148 GXI 20.09.../ DE000ME1AFM1 /
29/05/2024 18:21:37 | Var.- | Denaro08:00:28 | Lettera08:00:28 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.610EUR | - | 0.590 Quantità in denaro: 5,000 |
0.650 Quantità in lettera: 5,000 |
GERRESHEIMER AG | 148.00 EUR | 20/09/2024 | Call |
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents